Academic medical centers are examining whether commercial support for CME should be allowed to continue and how to prevent bias if it does. As consensus builds, a hodgepodge of different policies threatens confusion. Could Yale’s approach of allowing “principled” interactions become a national model?
Pfizer and Lilly shared their schedules for Viagra and Cialis ED ads with the Parents Television Council, which published them on its website so that parents bothered by the spots could shield their kids from them.
Johnson & Johnson said it’s returning some versions of children’s and infant’s Tylenol to stores after recalling millions of bottles earlier this year.
KnowledgePoint360 has acquired TGaS Advisors, provider of data and advice to pharma sales and marketing organizations.
FDA scraps adverse event definition
October 15, 2010
4:58 pm
Yielding to industry objections, FDA has abandoned its proposed definition for a suspected adverse drug reaction (SADR) in its just-finalized rule on clinical trial safety reporting.
DDMAC enforcement letters skyrocket
October 15, 2010
4:55 pm
As new resources come into FDA’s Division of Drug Marketing, Advertising and Commissions, it reports that it has exceeded last year’s totals for issuing warning and untitled letters sent to pharmaceutical marketers for violating agency advertising and promotion regulations.
Headliner: Lighthouse Learning’s Dr. Martin Samuels
Dr. Martin Samuels says the idea for Lighthouse Learning, a newly launched CME provider that eschews industry money and won’t conduct meetings or solicit exhibitors, had been evolving for years.
MM&M Awards 2010: Success is Golden
October 15, 2010
4:42 pm
The seventh annual MM&M Awards gala presentation took place October 12 in a new venue
Online behavior varies by condition type, stage: study
Consumers looking for diabetes information online respond to different tools and website functionality than, say, people looking for information on cancer or heart disease, a new study found.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix